Last reviewed · How we verify
NCT06998381: PS100B-G
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
trial in s100b in 200 participants. Currently enrolling.
1 August 2025
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Guadeloupe |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 February 2023 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 August 2025 |
| Sites | 2 locations across Guadeloupe |
Conditions studied
- s100b — all drugs for s100b →
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Who can join
Adults 18 to 65, any sex, with s100b. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Numerous studies have demonstrated the significant contribution of S100B blood level measurement in the management of minor to moderate traumatic brain injuries, notably by reducing the number of cranial computed tomography (CT) scans by at least one-third. However, physiological blood concentrations of the S100B protein may be higher in individuals with a Black phenotype compared to those with Asian or, in particular, Caucasian phenotypes. Assessing S100B protein levels in healthy individuals will help confirm the variability of its physiological concentration according to skin phenotype.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06998381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for s100b
Currently open trials in the same condition.
- NCT06984445 — Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia · recruiting
- NCT06893926 — Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction · recruiting
Other Centre Hospitalier Universitaire de la Guadeloupe trials
Trials by the same sponsor.
- NCT07266376 — Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS · NA · not yet recruiting
- NCT07292454 — Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe · not yet recruiting
- NCT07265986 — Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart · NA · recruiting
- NCT07330830 — Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (A · recruiting
- NCT07233447 — Prevalence of H. Pylori in Stomach Cancers in the West Indies · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06998381 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Guadeloupe
- Last refreshed: 31 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06998381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing